Biotech ADC Therapeutics Announces Completion of Enrollment of Phase 3 Confirmatory Clinical Trial of ZYNLONTA® in Combination with Rituximab in 2L+ Diffuse Large B-Cell Lymphoma December 31, 2024
Biotech Save The Giraffes spearheads breakthroughs in reproductive science in wild giraffes December 31, 2024
Biotech IDEAYA Biosciences Enters Exclusive License with Hengrui Pharma for SHR-4849, a Novel Phase 1 DLL3 Topo-I-Payload ADC Targeting SCLC and NET Solid Tumors December 30, 2024
Biotech Precigen Announces $79.0 Million Private Placement Offering of Convertible Preferred Stock December 28, 2024
Biotech FireflySci Inc. Announces Price Increase in Response to Proposed Import Tariffs December 27, 2024
Biotech FDA Proposes Rule to Require Standardized Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products December 27, 2024
Biotech AusperBio Secures $73 Million in Series B Financing to Advance Functional Cure for Chronic Hepatitis B December 27, 2024
Biotech Global Multiomics Market Expected to Grow Rapidly, with 13.5% Annual Increase from 2024 to 2029 December 25, 2024
Biotech Bio-Thera Solutions Partners with Tabuk Pharmaceuticals to Commercialize BAT2206, a Stelara® (Ustekinumab) Biosimilar in Saudi Arabia December 25, 2024